47
Galderma Group, a pure-play dermatology firm, has announced the price range, published its prospectus and started the book-building process, as part of its intention to IPO on the SIX Swiss Exchange.
The offering consists of up to 40,453,467 new shares and up to 276,909 existing shares with an over-allotment option of up to 6,109,158 existing shares (up to 15% of the base offer).
The price range for the offered shares has been set at CHF 49 to CHF 53 per share and will result in an offer size of approximately CHF2.3bn (US$2.6bn), assuming…